Navigation Links
Colorcon Reaffirms World-Wide Patent Positions for Enteric Coating Compositions
Date:3/23/2011

HARLEYSVILLE, Pa., March 23, 2011 /PRNewswire/ -- Colorcon, Inc., a wholly owned subsidiary of BPSI Holdings Inc., today announced specific details on its world-wide patent positions for enteric coating compositions in response to misleading statements made in the international press, particularly in India.  These communications have inaccurately summarized the status of certain patents and patent applications.   Colorcon has more than 15 patents for enteric coatings granted globally for the Acryl-EZE®, aqueous acrylic enteric, and Sureteric®, aqueous enteric systems, including valid patents in India.  These patents remain in full effect.  

"Colorcon will vigorously enforce its patent positions.  We are proud of our strong history of research and development and the resulting innovative products we provide our customers," stated Kamlesh Oza, General Manager for Film Coatings. "Colorcon endeavors to provide best-in-class products and services to the pharmaceutical industry globally.  Our recent customer survey indicates that, above all, the industry values our product range, technical support, and product use guidelines/application data.  Our intellectual property estate enables us to continue investing in the development of advanced products and continually provide the industry with next generation formulated systems with superior overall value."

About Colorcon

Colorcon is a world leader in the development, supply and support of formulated products for the pharmaceutical and nutritional industries. Its core businesses include film coatings, modified release technologies, functional excipients and tablet design services. Colorcon has 18 technical service laboratories globally and more than 1200 employees exclusively dedicated to its customer base.

The patents mentioned herein are owned by BPSI Holdings, Inc.  Colorcon is the exclusive licensee.


'/>"/>
SOURCE Colorcon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
2. Colorcon Acquires Pharmaceutical Excipient Company - NP Pharm
3. Colorcon Acquires Business of Pharmaceutical Coatings Pvt. Ltd. (India)
4. Colorcon Expands Nutraficient Product Portfolio to Include High Productivity, PVA-Based Formulations for Food Supplement Coating
5. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
6. Huifeng Bio-Pharmaceutical Reported Second Quarter 2010 Financial Results and Reaffirms its 2010 Guidance
7. Mylan Reports Adjusted Diluted EPS of $0.43; Reaffirms 2010 Adjusted Diluted EPS Guidance of $1.55 - $1.65
8. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
9. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
10. Matrixx Initiatives, Inc. Summarizes Ongoing Go-Shop Process and Board Reaffirms Recommendation
11. DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015   Leatt Corporation  (OTCQB: LEAT), a global ... all forms of sports, including extreme motor sports, and ... today that the UISP Lega Motociclismo Lombardia, an Italian ... to wear a neck brace during its racing competitions.  ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
Breaking Medicine Technology:Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... presented at the 43rd European Association for the Study of ... ... presented,today at the 43rd Annual Meeting of the European Association for ... the risk of ischemic cardiovascular disease in patients with type 2,diabetes. ...
... Sept. 18 A long-term study found,that a ... with life-threatening,diseases, such as leukemia and lymphoma, results ... males are likely to recover,from these changes over ... In addition, neither male nor female long-term cancer,survivors ...
Cached Medicine Technology:ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 2ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 2Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 4
(Date:1/22/2015)... with its top dressmaking technologies, has been a leading dress ... its latest designs of wedding dresses and launching a site-wide ... all the fresh new products are designed for 2015, and ... off. All the clothes from LunaDress follow up with the ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently delivers ... to have it lead the wedding dress industry into the ... dresses for the global market. , “The CEO of VogueQueen ... focuses on continuing the goal of operational excellence and giving ...
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Recently, Weddingshe.com has ... catalog, and has announced its highest annual revenues in the ... on its popular glamorous wedding dresses. , According to the ... important wedding dress promotions for them in 2015. This point ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2
... A diet that is high on fiber is perhaps ... especially in offsetting hemorrhoids. // Hemorrhoids, a condition characterized ... anus that can give rise to bleeding and uneasiness. ... Rectal Surgeons, hemorrhoids can be caused by a variety ...
... has created history by running over such long distances may ... District// Child Welfare Committee chairman R S Mishra. ... to Orissa Women and Child Welfare Minister Pramila Mallick. "The ... a long distance", he said. He added that the proposed ...
... near normal lung function and seem to perform lung ... patients//. Similarly, male lung cancer patients were likely to ... is characterized by progressive deterioration in lung function. The ... CHEST journal, a publication of the American College of ...
... variations among different states with urban states getting more ... the smallest firms (1-9 workers) pay an average 18% ... largest firms (1,000+ workers), when actuarial value--the percentage of ... into account, a new Commonwealth Fund-supported study finds. ...
... drug that can treat breast cancer. But NHS said that it ... breast cancer. // Due to this there are lots of legal ... to pay for the drug. The latest being a British man, ... told that his local NHS trust would fund for his treatment ...
... East the health service is losing more than ?50m because ... ,Despite years of similar complaint by NHS managers the situation ... Hospital in Huntingdon said: ‘Some people do not turn up ... cause us a lot of problems in lost capacity and ...
Cached Medicine News:Health News:Male Lung Cancer Patients Less Likely To Perform Well in Lung Function Tests 2Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3
The screening test for colorectal cancer that's simple, convenient, and effective....
A rapid, convenient, qualitative method for detecting asymptomatic occult bleeding....
... 500,000 people die each year of ... Despite diagnostic improvements (high contrast berium ... an increase in the success rate ... has not been achieved over the ...
... of guaiac as a test for the presence ... phenolic compounds present in guaiac to quinones, resulting ... blood is present, the heme portion of the ... catalyzing the release of oxygen from hydrogen peroxide ...
Medicine Products: